Literature DB >> 23513030

Treatment of myotendinous Achilles ruptures.

Jamal Ahmad1, Michael Repka, Steven M Raikin.   

Abstract

BACKGROUND: There is scant literature regarding the treatment of myotendinous Achilles ruptures. The purpose of this study was to retrospectively examine clinical outcomes from uniform nonsurgical treatment of these injuries.
METHODS: Between November 2005 and May 2011, 30 patients presented with an acute, complete myotendinous Achilles rupture. The location of the Achilles injury was confirmed on magnetic resonance imaging (MRI) for all patients. All patients were treated nonsurgically, which involved 3 weeks of non-weight-bearing and then 3 weeks of progressive to full weight-bearing in an Achilles boot. Physical therapy was provided for 4 to 6 weeks after this period of immobilization. 21 patients were male and 9 were female. The patients had a mean age of 40.8 years (range, 24-54). Patients were followed an average of 40.5 months (range, 23-81).
RESULTS: Full healing of the Achilles myotendinous junction was achieved clinically in all 30 patients . All patients experienced improved function and less pain at their latest follow-up. Mean Foot and Ankle Ability Measure-Sports (FAAM-Sports) increased from 20.2% at the time of initial presentation to 95.2% at the latest follow-up (P < .05). Mean Visual Analog Scores (VAS) of pain decreased from 8.2 at the time of initial presentation to 1.3 at latest follow-up (P < .01). In all, 23 (76.7%), 6 (20%), and 1 (3.3%) patients rated their satisfaction as excellent, good, and fair, respectively. No patients have developed recurrent myotendinous Achilles ruptures to date.
CONCLUSION: Nonsurgical treatment of myotendinous Achilles ruptures results in a high rate of myotendinous healing with improved patient function and pain relief. LEVEL OF EVIDENCE: Level IV, retrospective case series.

Entities:  

Keywords:  Achilles boot; magnetic resonance imaging (MRI); nonsurgical; tendon

Mesh:

Year:  2013        PMID: 23513030     DOI: 10.1177/1071100713483115

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  7 in total

1.  Achilles tendon ruptures.

Authors:  David Pedowitz; Greg Kirwan
Journal:  Curr Rev Musculoskelet Med       Date:  2013-12

2.  Surgical Repair of Achilles Tendon Rupture by Turn-O-Plasty: A Case Report.

Authors:  Sarthak Gupta; Ankur Salwan; Gajanan L Pisulkar; Amit Saoji; Shounak Taywade
Journal:  Cureus       Date:  2022-09-11

3.  Reliability and validity of the Polish version of the Achilles tendon Total Rupture Score.

Authors:  Paweł Bąkowski; Szymon Rubczak; Maria Wolff-Stefaniak; Monika Grygorowicz; Tomasz Piontek
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-01       Impact factor: 4.342

4.  Factors Affecting Return to Play After Primary Achilles Tendon Tear: A Cohort of NFL Players.

Authors:  JaeWon Yang; Jonathan D Hodax; Jason T Machan; Michael K Krill; Nicholas J Lemme; Wesley M Durand; Joshua T Hoffman; Timothy E Hewett; Brett D Owens
Journal:  Orthop J Sports Med       Date:  2019-03-12

Review 5.  Spectrum of Tendon Pathologies: Triggers, Trails and End-State.

Authors:  Sara Steinmann; Christian G Pfeifer; Christoph Brochhausen; Denitsa Docheva
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

6.  Return to play post-Achilles tendon rupture: a systematic review and meta-analysis of rate and measures of return to play.

Authors:  Jennifer A Zellers; Michael R Carmont; Karin Grävare Silbernagel
Journal:  Br J Sports Med       Date:  2016-06-03       Impact factor: 13.800

7.  Treatment of Achilles Tendinopathy in Recreational Runners with Peritendinous Hyaluronic Acid Injections: A Viscoelastometric, Functional, and Biochemical Pilot Study.

Authors:  Marco Gervasi; Elena Barbieri; Italo Capparucci; Giosuè Annibalini; Davide Sisti; Stefano Amatori; Vittoria Carrabs; Giacomo Valli; Sabrina Donati Zeppa; Marco Bruno Luigi Rocchi; Vilberto Stocchi; Piero Sestili
Journal:  J Clin Med       Date:  2021-03-31       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.